The estimated Net Worth of Robin Toft is at least 13.3 千$ dollars as of 15 September 2023. Ms. Toft owns over 2,300 units of T2 Biosystems Inc stock worth over 13,276$ and over the last 4 years she sold TTOO stock worth over 0$. In addition, she makes 0$ as Independent Director at T2 Biosystems Inc.
Robin has made over 6 trades of the T2 Biosystems Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 2,300 units of TTOO stock worth 5,290$ on 15 September 2023.
The largest trade she's ever made was exercising 73,224 units of T2 Biosystems Inc stock on 25 June 2022 worth over 168,415$. On average, Robin trades about 13,972 units every 70 days since 2020. As of 15 September 2023 she still owns at least 5,772 units of T2 Biosystems Inc stock.
You can see the complete history of Ms. Toft stock trades at the bottom of the page.
Robin Toft serves as Independent Director of the Company. Robin Toft is the founder and CEO of Toft Group, a ZRG company, where she combines a deep inside knowledge of the life science industry with a passion for building game-changing management teams. Ms. Toft has placed hundreds of executives at innovation-led life science companies. A champion of diverse executive teams, she has built a reputation for recruiting women and minorities into C-level and board of director roles. Prior to founding Toft Group in 2010, Ms. Toft served 20+ years as a biotech executive, most recently as Senior Vice President, Commercial Operations at Roche Molecular Diagnostics. In the 2020 American Business Awards, Ms. Toft received three Gold awards for Lifetime Achievement, Maverick of the Year and Woman of the Year. She currently serves on The Clearity Foundation board for ovarian cancer care, and is Chairman of LEAD San Diego, dedicated to developing civically engaged leaders. Ms. Toft earned a Bachelor of Science from Michigan State University.
Robin Toft is 59, she's been the Independent Director of T2 Biosystems Inc since 2020. There are 7 older and 11 younger executives at T2 Biosystems Inc. The oldest executive at T2 Biosystems Inc is John Cumming, 74, who is the Lead Independent Director.
Robin's mailing address filed with the SEC is 101, Hartwell Avenue, Lexington, Middlesex County, Massachusetts, 02421, United States.
Over the last 10 years, insiders at T2 Biosystems Inc have traded over 18,971,153$ worth of T2 Biosystems Inc stock and bought 5,875,341 units worth 59,722,018$ . The most active insiders traders include Adrian M Jones、Group L.P.Crg Partners Iii ...、Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of 764,499$. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth 154$.
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Inc executives and other stock owners filed with the SEC include: